Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$536K Sell
1,479
-34
-2% -$11.6K 0.04% 204
2026
Q1
$532K Buy
1,513
+616
+69% +$220K 0.04% 190
2025
Q4
$294K Sell
897
-16
-2% -$5.08K 0.02% 241
2025
Q3
$258K Sell
913
-144
-14% -$41.8K 0.02% 221
2025
Q2
$295K Buy
1,057
+32
+3% +$9.06K 0.03% 192
2025
Q1
$319K Sell
1,025
-277
-21% -$81.8K 0.03% 171
2024
Q4
$339K Sell
1,302
-101
-7% -$30K 0.03% 163
2024
Q3
$452K Buy
1,403
+132
+10% +$43.2K 0.05% 141
2024
Q2
$397K Buy
1,271
+72
+6% +$21.2K 0.04% 142
2024
Q1
$341K Buy
+1,199
New +$351K 0.04% 144
2023
Q1
Sell
-1,719
Closed -$451K 164
2022
Q4
$451K Buy
+1,719
New +$461K 0.09% 107
2021
Q1
$291K Buy
1,171
+110
+10% +$26.2K 0.1% 117
2020
Q4
$244K Buy
+1,061
New +$245K 0.1% 111

Other funds holding AMGN

MBL Wealth's AMGN Position: Q2 2026 in Review

MBL Wealth reduced its Amgen (AMGN) stake by 2.2% in Q2 2026, selling an estimated $11.6K and leaving 1,479 shares worth $536K. The position accounts for 0.04% of the portfolio, ranked #204.

MBL Wealth first reported a position in AMGN in Q4 2020 and has held it in 13 quarters since. 1,630 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • MBL Wealth held 1,479 shares of Amgen worth $536K as of Q2 2026.
  • MBL Wealth sold 34 Amgen shares in Q2 2026, an estimated $11.6K.
  • Amgen made up 0.04% of MBL Wealth's portfolio in Q2 2026, its #204 holding.
  • MBL Wealth first reported a position in Amgen in Q4 2020 and has held it in 13 quarters since.
  • 1,630 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on MBL Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.